Table 7.
THA results, complications, and survival from any revision based on the type of childhood management for LCPD
| THA results, general complications, and survival | Surgically treated patients | Conservatively treated patients | p value |
|---|---|---|---|
| Hips | 30 | 69 | |
| General complication rate | 6 (20%) | 10 (14%) | 0.5 |
| Fracture | 2 (7%) | 7 (10%) | 0.6 |
| Neurological deficit | 2 (7%) | 1 (1%) | 0.16 |
| Reported postoperative Harris hip score (HHS) | 29 | 66 | |
| Postoperative HHS | 87 ± 14 | 88 ± 14 | 0.69 |
| Reported HHS change | 20 | 56 | |
| The HHS change | 30 ± 19 | 31 ± 15 | 0.84 |
| THA survival from any revision† at | |||
| 4 years | 100% | 100% | 0.9 |
| THA at risk | 22 | 53 | |
| 8 years | 91% (56–99) | 88% (75–95) | |
| THA at risk | 11 | 33 | |
| 12 years | 73% (32–94) | 85% (70–93) | |
| THA at risk | 3 | 13 | |
* Value expressed as mean ± SD: †values are expressed as the Kaplan-Meier survival estimate, with the 95% confidence interval in parentheses; LCPD = Legg-Calvé-Perthes disease.